Member Info for PrivateRyan

I recall a proactive video recently where a frustrated DC said that profits were about equal to the market cap.At that time it was around 7m. So my own target would be 10 times PE on 7m less say 20 % for tax . That gives a market cap around 56m
At 6.5 p it is currently valued at 12m,so there is room for a four fold increase from here . Of course all that is broad brush ,but it seems to me that somewhere in the 20s is readily achievable ,and I am expecting the brokers report due imminently to support a much increased valuation from here .

I have added a further £9.7k . I think the independent report will be hugely positive,and there will be further news soon.
I hope I am right!

not all readers!
the CEO has commissioned this independent report for a reason- he knows it will support what he has been saying for a while which the market so far is taking with a pinch of salt. Days to go for that to be published. Its worth a further addition in my view.

nope. The dilution went through but not the warrants

suspect it's traders loading up in anticipation of detailed trading update promised for mid june.....hope I am wrong though.....

the analyst doesnt mention that iqai receives regular research grants.I recall good old david smith enthusing about them .
he also intimated that the chairman had a history of building companies and then selling them i think that is the plan personally if we get the right offer.....
enjoy the break

you're welcome donald!

Beacuse you have to value stock for accounts at the lower of cost and net realisable value. No choice

This is an extract from the report. I really dont know why the company couldnt have set out the schedule for FDA response within the RNS. Very poor. I think the FDA have to respond within 15 days to say they have all they need ,and then the 3 months kick in.
Thanks very much for you two posters sharing probably the most detailed report I have seen.Worth another read I reckon. Cheers Extract below
IB has recently prepared a pre-market 501(k) application to the U.S. FDA, which is expected to
be submitted in the near-term. The application claims IB Zero G is safe, effective and
substantially equivalent to a legally marketed device. IB leadership expects a favorable
response within three months, enabling commercial introduction of IB Zero G before the end of
2022

https://apple.news/At3sHEgY6SeiLzu0QfNhq9A
Hospital it systems down

I see we got a trading update early June 2021. Hopefully TOm will have a lot to say soon!

Hi all. Just to say the good news (potentially) is that there was an article in the Sunday telegraph today saying that the new Tempest fighter aircraft will have eye tracking to speed decision making. It doesn't mention SEE ....The bad news is it is commissioned to start flying in 2035! Hope I am still around by then.!

I have been pondering why IQAI doesnt mention the accounting policy for grants . If Trevor is looking at this board you can see that POLX has such a policy , Yours a former ACA.

page 80 of doc

IG and IT are aware that there is
use of data sharing apps at the
Trust which could pose significant
data security risks if unregulated or
used for business purposes on
personal devicesNo controls in place for staff personal devices.

MDM policy will be reviewed at Information Governance Group,
(IGG) 03/05/22

Communications to all staff regarding use of apps will be
reviewed by IGG 01/03/22 - subsequent dissemination.
Bleepa to the rescue.
well done old tramp

Yes skippy

great info vas! My god the pace is certainly gathering. I wish Tom would at least comment on whether we are partnering in this expansion.

news may be due shortly as the year end results normally come out soon.Also the 510k application for gad free imaging is imminent-see last newsletter. Get back in quick lol!

less than 1 per cent dilution. insignificant.
The calm now before the whirlwind as streaming news released

good info -well done

agree with all that- the problem is that with projected inflation and interest rises the future income stream is being discounted ,in particular for higher growth companies such as see. But as Paul said the market doesnt currently believe the projections ,so there is lots of room for share price appreciation if he macdelivers!